Hydrogenation catalyst generates cyclic peptide stereocentres in sequence.

Area of Science:

• Organic Chemistry
• Catalysis
• Medicinal Chemistry

Background:

• Molecular recognition is crucial in biological systems, influencing enzyme specificity, gene regulation, and disease treatment.
• Harnessing molecular recognition principles can advance synthetic organic chemistry and drug discovery.

Purpose of the Study:

• To develop a synthetic catalyst that mimics enzymatic molecular recognition for organic synthesis.
• To achieve selective and stereoselective synthesis of cyclic peptides using a rhodium-based catalyst.

Main Methods:

• Utilized a synthetic rhodium-based catalyst for selective binding of dehydroamino acid residues.
• Conducted combined experimental and theoretical studies to elucidate reaction mechanisms.
• Investigated catalyst-substrate interactions to understand stereocontrol in cascade reduction.

Main Results:

• Demonstrated selective binding of a dehydroamino acid residue by the rhodium catalyst.
• Achieved sequential and stereoselective synthesis of cyclic peptides.
• Revealed that catalyst dissociation, not processivity, dictates C to N directionality in cascade hydrogenation.

Conclusions:

• Catalyst-substrate recognition, rather than a processive mechanism, governs the stereochemical outcome of cyclic peptide synthesis.
• The mechanistic insights provide a foundation for developing novel cascade hydrogenation strategies.
• This approach offers a powerful tool for the synthesis of complex cyclic peptides with high stereocontrol.